NanoVibronix
Therapeutic Devices Based on Ultrasound Technology
Startup Public Health Tech & Life Sciences Est. 2003
Total Raised
$24.5M
Public
Last Round
$5M
9 rounds
Investors
1
1 public
Team
4
11-50 employees
Confidence
100/100
News
93
articles
Patents
1
About
NanoVibronix develops medical devices based on a proprietary therapeutic ultrasound technology. Its products address a range of clinical applications including catheter-related injuries and their complications, pain, and soft tissue healing. The company's patented technology allows for the creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. The technology can be utilized for a variety of medical applications requiring low-cost ultrasound therapy. The NanoVibronix PainShield device is a wearable, battery-powered electronic unit that uses a disposable patch through which it delivers localized energy, creating a therapeutic effect to relieve localized pain and induce soft tissue healing. PainShield has gained CE Mark certification and also carries FDA clearance. The UroShield system is a multi-targeted solution intended to work with a number of factors essential to preventing catheter-related complications. The device is CE mark certified. The company's WoundShield, designed to accelerate wound healing, may also be used to enhance oxygen and topical drug delivery.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
SensingAcousticsSimulation & ImagingUltrasound
Target Customer
Healthcare & Life SciencesHealthcareProvidersPatients
Business Model
B2CB2B
Tags
ultrasoundwearablepain-reliefmedical-devicesurologytherapeutic-devicesmedical-productshome-carenanotechnology
Funding & Events
Nov 2017
Exit Undisclosed
Nov 2011
Seed $300K
Mar 2015
Convertible Debt $1.5M
Jun 2019
PIPE $3.2M
Undisclosed Investor(s)
Dec 2022
PIPE $2.4M
Undisclosed Investor(s)
Dec 2020
PIPE $6M
Undisclosed Investor(s)
Dec 2011
Convertible Debt $1M
Aug 2023
PIPE $5M
Undisclosed Investor(s)
Apr 2014
Exit Undisclosed
News (93)
Oct 21, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Inc. (NAOV): 2025 Product Pipeline and Strategy Analysis Report
Product Stage
Sep 18, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Launches "Oscar" Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities
Product StageCustomers
Sep 16, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PIPE/PO
Sep 15, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio
Sep 4, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology
Product Stage
Aug 8, 2025 · finance.yahoo.com
growth-negative
NanoVibronix Announces Reverse Stock Split
Jul 18, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock
Investment
Jun 26, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation
Product Stage
Jun 24, 2025 · finance.yahoo.com
growth-positive
NanoVibronix’s ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement
CustomersProduct Stage
Jun 11, 2025 · finance.yahoo.com
growth-positive
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System
Product Stage
Jun 4, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces CEO Transition
Management ChangesAcquisition
May 28, 2025 · finance.yahoo.com
growth-positive
Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures
Customers
May 16, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants
PIPE/PO
May 15, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants
PIPE/PO
May 12, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces Results from UroShield™ Case Series
Product Stage
Apr 11, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Regains Nasdaq Compliance
Apr 1, 2025 · finance.yahoo.com
growth-positive
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
Partners
Mar 21, 2025 · finance.yahoo.com
growth-positive
Why Nanovibronix Inc. (NAOV) Surged On Thursday?
Mar 14, 2025 · finance.yahoo.com
growth-positive
Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal
Mar 12, 2025 · finance.yahoo.com
growth-negative
NanoVibronix Announces Reverse Stock Split
+ 73 more articles
Details
Product Stage
Released
Employees
11-50
Exact Count
13
District
North District
Founded
2003
Registrar
513483164
Crunchbase
nanovibronix
Locations
Derech HaShalom 9, Nesher, Israel
525 Executive Blvd Elmsford, NY 10523, USA
Links
Website
LinkedIn
Twitter
Facebook
Admin
Last Update
Oct 22, 2025
Verified by
Sharon Shapira
Claimed
Yes
Missing
markets
Team (4)
Brian Murphy
CEO
Harold Jacob
CMO
Itai Levinson
SVP Sales & Marketing
Amir Rippel
VP Marketing
Internal
Created by
Rebecca Mack (rebeccamack26@gmail.com)
Created
2014-07-20T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Status
Public on NASDAQ on Apr, 2014<br>